Aureka Biotechnologies: Funding, Investors & Team (Oct 2026)
Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in order to conquer sickness.
Aureka Biotechnologies has raised $135M across 2 funding rounds on record, the most recent a Series B of $100M announced in Aug 2026.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Aureka Biotechnologies Company Profile and Key Stats
Latest funding round on record: Aug 2026.
Aureka Biotechnologies Funding Rounds
Aureka Biotechnologies raised $35.0M in a Series A announced in Apr 2026.
4 months later, a Series B of $100M was announced in Aug 2026.
Aureka Biotechnologies Investors
10 investors are recorded in total; the 5 named above are those the record identifies.
Aureka Biotechnologies Founders and Leadership Team
Contact details for the Aureka Biotechnologies team: 2 of 2 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Aureka Biotechnologies Funding Compared to Other Biotechnology Startups
Aureka Biotechnologies' latest round of $100M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Aureka Biotechnologies in Biotechnology and Laguna Hills
Companies Similar to Aureka Biotechnologies
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Aureka Biotechnologies Funding FAQs
What does Aureka Biotechnologies do?
Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in order to conquer sickness.
How much funding has Aureka Biotechnologies raised?
Aureka Biotechnologies has raised $135M across 2 rounds on record. The most recent is a Series B of $100M announced in Aug 2026.
When did Aureka Biotechnologies last raise funding?
Aureka Biotechnologies' most recent funding round on record is a Series B of $100M, announced in Aug 2026.
Who has invested in Aureka Biotechnologies?
Investors on record for Aureka Biotechnologies include Matrix Partners China, Qiming Venture Partners, Granite Asia, 5Y Capital, HongShan. FundedIQ records 10 investors in total.
Who founded Aureka Biotechnologies?
FundedIQ lists Alon Wellner (VP Biology and Co-founder), Weian Zhao (Founder) at Aureka Biotechnologies.
Where is Aureka Biotechnologies headquartered?
Aureka Biotechnologies is based in Laguna Hills, California, United States.
How many employees does Aureka Biotechnologies have?
Aureka Biotechnologies is in the 11-50 employee band.
When was Aureka Biotechnologies founded?
Aureka Biotechnologies was founded in 2023.
How does Aureka Biotechnologies' funding compare to other Biotechnology startups?
Aureka Biotechnologies' latest round of $100M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Aureka Biotechnologies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Aureka Biotechnologies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.